But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...

Key Takeaways Tirzepatide may be more effective than semaglutide or liraglutide for weight loss, as it has a dual mechanism of action. Semaglutide has the longest half-life of the three, which may ...

When prescribing glucagon-like peptide 1 (GLP-1) medications, many physicians prefer tirzepatide over the more well-known semaglutide due to its superior efficacy in weight loss and A1c reduction.

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity ...

Semaglutide and a similar GLP-1 drug, tirzepatide (Mounjaro/Zepbound), had been on the FDA’s shortages list since 2022, as ...

U.S. Customs and Border Protection officers in Cincinnati recently seized more shipments containing unapproved medications.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...